Wednesday, December 24, 2025

P&K Skin Clinical Research Center, Continues Growth with K-Beauty Expansion

Input
2025-08-19 08:30:20
Updated
2025-08-19 08:30:20
KB Securities Report

[Financial News] The skin human application test specialist company P&K Skin Clinical Research Center (P&K) is expected to continue its performance growth in the second half of the year due to global cosmetic regulatory changes and the expansion of K-Beauty.
KB Securities researchers Seong Hyun-dong and Jeon So-hee stated in a report on the 18th, "P&K achieved a record-high half-year performance since its founding, with sales reaching 11.9 billion won in the first half of this year, a 49.3% increase compared to the same period last year," and "Operating profit was 2.7 billion won, with an operating profit margin of 22.9%, significantly improving profitability compared to the same period last year."
The researchers explained, "After the implementation of the U.S. Modernization of Cosmetics Regulation Act (MoCRA), the demand for sunscreen product testing surged," and "P&K strengthened its services to meet the U.S. Food and Drug Administration (FDA) broad spectrum test standards, gaining trust from global clients." In fact, the number of P&K sunscreen test cases is continuously increasing.
They continued, "P&K has established a Global Regulatory Cooperation Team to provide specialized consulting solutions that support indie brands and startups in entering major markets such as the United States and Europe, assisting with legal and certification procedures," and "The strength is that brands can minimize risks such as fines, recalls, and sales suspensions."
P&K is expected to increase orders in the second half of the year. The researchers analyzed, "While continuing collaboration with major global cosmetic conglomerates, the entry of new indie brands is increasing, further enhancing the potential for order growth."
Subsidiary KOONIRICA is also actively pursuing North American and European color cosmetics projects, targeting the global color market. The researchers forecasted, "P&K, based on a stable financial structure with net cash assets of 72.1 billion won, is expanding into overseas markets, and there is a high possibility of breaking the record for maximum annual performance this year."

butter@fnnews.com Kang Kyung-rae Reporter